Key Responsibilities:
Compile and perform initial review of US labeling documents for:
Original ANDA submissions
Additional strength submissions
Coordinate with Cross-Functional Teams (CFTs) to ensure alignment on priorities, roles, and regulatory filing timelines.
Proactively follow up with internal stakeholders to obtain labeling documents within defined timelines and ensure completeness of all labeling modules prior to submission.
Stay current with US labeling regulations, FDA guidance, and industry best practices
Ensure availability and readiness of all labeling modules for:
Complete Response (CR)
Information Request (IR)
Deficiency Response Letter (DRL) submissions
Coordinate with cross-functional teams to collect and compile required documents for responses.
Ensure 100% launch readiness for all new products with zero labeling-related issues, including:
Issuance of most current, approved labeling (Ok-To-Print)
Timely availability of printed labeling for product launch
Drug listing completion for first-launch products post-approval
Assist in reviewing Reference Listed Drug (RLD) labeling updates for OSD and Injectables and ensure timely submission of updated labeling modules. Coordinate with supervisor to align priorities.
Initiate and facilitate Change Controls and Labeling Review Committee (LRC) activities for all labeling changes.
Address and track annual reportable labeling changes
Manage Safety Labeling Change Notifications in compliance with regulatory requirements.
Demonstrate strong knowledge of Patent and Exclusivity considerations, including labeling carve-outs.
Support development, revision, and compliance of labeling SOPs
Required Skills & Competencies:
Strong understanding of US FDA labeling regulations for OSD and Injectable products
Excellent written and verbal English communication skills
Strong coordination, follow-up, and documentation skills
High attention to detail with the ability to manage multiple priorities effectively
Master's Degree
Amneal (NASDAQ: AMRX) is rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Our family delivers for yours through a robust U.S. generics business, a growing branded business and deepening portfolios in injectables, biosimilars and select international markets. We’ve bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. And we invest substantially in our people through leadership development and employee well-being programs – all so we can deliver even more value. We are Amneal and We make healthy possible.
Content is for informational purposes only and 3rd party content does not reflect Amneal’s opinions.
Amneal has the right to remove comments that violate another’s copyright or intellectual property, mention an Amneal product, use profanity or are defamatory, promote and solicit for third-party sites, initiatives, or products, or are factually inaccurate or misleading or spam.
Amneal recommends that you consult with your healthcare provider regarding personal health matters. To report a product complaint or adverse event related to an Amneal product, contact Drug Safety at 877-835-5472, option 3 or drugsafety@amneal.com. If you are currently experiencing a life-threatening event, please immediately contact 911.
